Mayo Clinic Platform supports clinical research and AI development more effectively than traditional EHRs, according to researchers at the Rochester, Minn.-based health system.
The Feb. 16 study in npj Health Systems demonstrated the capabilities of Mayo Clinic Platform, a cloud-based data and analytics ecosystem with over 15 million deidentified patient records, by simulating clinical trials and predicting disease states with AI and deep learning.
“[Mayo Clinic Platform] enables broader accessibility and standardization compared to institutional EHRs, positioning it as a powerful platform for advancing translational research and precision medicine,” the authors concluded.
The advantages of Mayo’s approach include availability to external researchers, built-in analytics tools, and data harmonization for cross-organization comparisons, the researchers wrote.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
